Home / News / India News / Article /
Rs 35,000 crore budgeted for COVID-19 vaccination expenditure in 2021-22 fiscal
Updated On: 01 February, 2021 12:00 AM IST | New Delhi | PTI
India had earlier in January approved two vaccines -- Oxford's Covishield manufactured by SII and Bharat Biotech's Covaxin -- for restricted emergency use.
Listen to this article :
Photo used for representational purpose
Finance Minister Nirmala Sitharaman on Monday provided Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal.
"I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I'm committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent," she said while presenting 2021-22 Budget in the Lok Sabha.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT